Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

An Epidemic of Parvovirus B19-Induced Aplastic Crises in Pediatric Patients with Hereditary Spherocytosis Following the Covid-19 Pandemic

A Single-Center Retrospective Study

Bibliographic Data

ID15719409
AuthorsPaola Giordano (0000-0002-7762-3500, University of Bari Aldo Moro), Valentina Palladino (0000-0002-3976-6463, University of Bari Aldo Moro), Giuseppe Lassandro (0000-0001-7858-1632, University of Bari Aldo Moro), Stella Spina (0009-0005-0328-7822, University of Bari Aldo Moro), Giancarlo Vecchio (0000-0001-5462-0027, University of Bari Aldo Moro, corresponding author)
Year2025
Volume12
Issue6
Pages772-772
Publication date2025-06-13
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueChildren (JOURNAL)
Journal identifiersISSN: 2227-9067 • E-ISSN: 2227-9067
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/children12060772
PMID40564730
OpenAlexW4411338026
LanguageEN
References cited40

Background: Parvovirus B19 is the major cause of transient aplastic crisis in children with hereditary spherocytosis (HS) inhibiting erythropoiesis and leading to a severe drop in hemoglobin levels, requiring hospitalization and transfusional support. During the COVID-19 pandemic, the circulation of non-COVID respiratory viruses, such as parvovirus B19, initially declined but subsequently increased abruptly following the relaxation of containment strategies. Moreover, it remains unclear whether this has resulted in a rise in parvovirus B19-induced aplastic crises among individuals with HS. Methods: This retrospective, single-center study conducted at the Pediatric University Hospital of Bari (Italy) aims to describe the clinical characteristics and frequency of parvovirus B19-induced aplastic crises in pediatric patients with HS before and after the COVID-19 Public Health Emergency of International Concern (PHEIC, 30 January 2020-5 May 2023). The study was divided into four distinct periods: Period A: from 1 December 2018 to 31 December 2019, representing one year before the declaration of the PHEIC; Period B: from 1 June 2023 to 30 June 2024, representing one year after the cessation of the PHEIC; Period C: before 1 December 2018; Period D: from 1 January 2020 to 31 May 2023, which refers to the pandemic period. Results: A total of 30 patients (55% of the study population, n = 55) experienced a parvovirus B19-induced aplastic crisis. The frequency of these crises in Period B was significantly higher than in Period A ( p Conclusions: This study suggests a substantial increase in parvovirus B19-induced aplastic crises among children with HS following the COVID-19 outbreak indicating a potential impact of public health containment strategies on parvovirus B19 infection rates

2019-20 coronavirus outbreak · Coronavirus disease 2019 (COVID-19 · Disease · Hereditary spherocytosis · Infectious disease (medical specialty · Outbreak · Pandemic · Parvovirus · Spherocytosis · Splenectomy · Virus · Dermatological and COVID-19 studies · Erythrocyte Function and Pathophysiology · Medicine · Parvovirus B19 Infection Studies · Immunology · Internal Medicine · Pediatrics · Virology

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae